Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/25 17:06 | 1/27/25 | PCSA | Health | Drug | Pharmaceutical Preparations | Yorke Justin W | MD | D | 1 | P | 10 | 0.7975 | 0 | 12 | 35 | 47 | I | |||||||||||||||
1/29/25 17:05 | 1/27/25 | PCSA | Health | Drug | Pharmaceutical Preparations | Ng George K | MD | DO | CEO | 1 | P | 70 | 0.7975 | 0 | 87 | 436 | 107 | I | ||||||||||||||
1/29/25 16:24 | 1/27/25 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DO | P Resear | 1 | P | 99 | 0.7975 | 0 | 125 | 88 | 266 | D | ||||||||||||||
1/29/25 16:20 | 1/27/25 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | 1 | P | 35 | 0.7975 | 0 | 44 | 150 | 73 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |